Capability of hypertonic saline cough provocation test to predict the response to inhaled corticosteroids in chronic cough: a prospective, open-label study

Cough

Minna K Purokivi¹  Heikki O Koskela¹ 

[1] Unit for Medicine and Clinical Research, Pulmonary Division, Kuopio University Hospital, PL 1777, Kuopio 70211, Finland

关键词: Nitric oxide;    Airway hyperresponsiveness;    Cough provocation tests;    Inhaled corticosteroids;    Chronic cough;   

Others  :  809242
DOI  :  10.1186/1745-9974-9-15

 received in 2012-11-13, accepted in 2013-05-15,  发布年份 2013

【 摘 要 】

Background

Many patients with chronic cough respond to treatment with inhaled corticosteroids but it is difficult to predict which patients are likely to respond. The primary aim of the present study was to define the capability of hypertonic saline cough provocation test to predict the responsiveness to inhaled corticosteroids in chronic cough. The secondary aim was to assess the ability of the saline test to monitor the healing of cough during corticosteroid treatment.

Methods

Forty-three patients with chronic cough were recruited. Before therapy, spirometry, ambulatory peak flow monitoring, nitric oxide measurement, histamine airway challenge, and saline test were performed. Those responding to the first saline test repeated it and the nitric oxide measurement during the subsequent visits. The patients used inhaled budesonide, 400 ug twice daily, for twelve weeks. The treatment response was assessed by Leicester Cough Questionnaire at baseline, and at one, four, and twelve weeks.

Results

Seventy-seven % of the patients demonstrated the minimal important difference in the Leicester Cough Questionnaire indicating a symptomatic response. Neither the response magnitude nor the speed was predicted by the saline test. Histamine challenge showed the strongest predictive ability: The maximal improvement in Leicester Cough Questionnaire total score was 5.08 (3.76 – 6.40) points in the histamine positive and 2.78 (1.55 – 4.01) points in the histamine negative subjects (p = 0.006). Baseline nitric oxide level also associated with the improvement in Leicester Cough Questionnaire total score (p = 0.02). During the treatment, the cough sensitivity to saline gradually decreased among the budesonide responders but not in the non-responders. Nitric oxide levels decreased very rapidly among the responders.

Conclusions

Saline test cannot predict the responsiveness to inhaled corticosteroids in chronic cough but it may be utilized to monitor the effect of this treatment.

Trial registration

The study was registered in ClinicalTrials.gov database (KUH5801112). ClinicalTrials.gov Identifier: NCT00859274

【 授权许可】

   
2013 Koskela and Purokivi; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Morice AH, McGarvey L, Pavord I: Recommendations for the management of cough in adults. Thorax 2006, 61:i1-i24.
• [2]Morice AH, Fontana GA, Belvisi MG, Birring SS, Chung KF, Dicpinigaitis PV, Kastelik JA, McGarvey LP, Smith JA, Tatar M, Widdicombe J: Ers guidelines on the assessment of cough. Eur Respir J 2007, 29:1256-1276.
• [3]Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, Brown KK, Canning BJ, Chang AB, Dicpinigaitis PV, Eccles R, Glomb WB, Goldstein LB, Graham LM, Hargreave FE, Kvale PA, Lewis SZ, McCool FD, McCrory DC, Prakash UB, Pratter MR, Rosen MJ, Schulman E, Shannon JJ, Smith Hammond C, Tarlo SM: Diagnosis and management of cough executive summary: Accp evidence-based clinical practice guidelines. Chest 2006, 129:1S-23S.
• [4]Pizzichini MM, Pizzichini E, Parameswaran K, Clelland L, Efthimiadis A, Dolovich J, Hargreave FE: Nonasthmatic chronic cough: no effect of treatment with an inhaled corticosteroid in patients without sputum eosinophilia. Can Respir J 1999, 6:323-330.
• [5]Chaudhuri R, McMahon AD, Thomson LJ, MacLeod KJ, McSharry CP, Livingston E, McKay A, Thomson NC: Effect of inhaled corticosteroids on symptom severity and sputum mediator levels in chronic persistent cough. J Allergy Clin Immunol 2004, 113:1063-1070.
• [6]Hahn PY, Morgenthaler TY, Lim KG: Use of exhaled nitric oxide in predicting response to inhaled corticosteroids for chronic cough. Mayo Clin Proc 2007, 82:1350-1355.
• [7]Prieto L, Ferrer A, Ponce S, Palop J, Marin J: Exhaled nitric oxide measurement is not useful for predicting the response to inhaled corticosteroids in subjects with chronic cough. Chest 2009, 136:816-822.
• [8]Undem BJ, Carr MJ, Kollarik M: Physiology and plasticity of putative cough fibres in the guinea pig. Pulm Pharmacol Ther 2002, 15:193-198.
• [9]Lalloo UG, Fox AJ, Belvisi MG, Chung KF, Barnes PJ: Capsazepine inhibits cough induced by capsaicin and citric acid but not by hypertonic saline in guinea pigs. J Appl Physiol 1995, 79:1082-1087.
• [10]Koskela H, Purokivi M, Nieminen R, Moilanen E: The cough receptor trpv1 agonists 15(s)-hete and ltb4 in the cough response to hypertonicity. Inflamm Allergy Drug Targets 2012, 11:102-108.
• [11]Koskela HO, Hyvarinen L, Brannan JD, Chan HK, Anderson SD: Coughing during mannitol challenge is associated with asthma. Chest 2004, 125:1985-1992.
• [12]Koskela HO, Kontra KM, Purokivi MK, Randell JT: Interpretation of cough provoked by airway challenges. Chest 2005, 128:3329-3335.
• [13]Koskela HO, Purokivi MK, Kontra KM, Taivainen AH, Tukiainen HO: Hypertonic saline cough provocation test with salbutamol pre-treatment: Evidence for sensorineural dysfunction in asthma. Clin Exp Allergy 2008, 38:1100-1107.
• [14]Purokivi M, Koskela HO, Koistinen T, Magga J, Peuhkurinen K, Kiviniemi V, Kontra KM: Utility of cough response during hypertonic histamine challenge in diagnosing asthma. Respir Med 2008, 102:1379-1384.
• [15]Purokivi M, Koskela H, Brannan JD, Kontra K: Cough response to isocapnic hyperpnoea of dry air and hypertonic saline are interrelated. Cough 2011, 7:8. BioMed Central Full Text
• [16]Purokivi M, Koskela H, Kontra K: Determinants of asthma control and quality of life in stable asthma: Evaluation of two new cough provocation tests. Clin Respir J 2012. epub ahead print
• [17]Dettmar PW, Strugala V, Fathi H, Dettmar HJ, Wright C, Morice AH: The online cough clinic: developing guideline-based diagnosis and advice. Eur Respir J 2009, 34:819-824.
• [18]Sovijarvi AR, Malmberg LP, Reinikainen K, Rytila P, Poppius H: A rapid dosimetric method with controlled tidal breathing for histamine challenge. Repeatability and distribution of bronchial reactivity in a clinical material. Chest 1993, 104:164-170.
• [19]Birring SS, Prudon B, Carr AJ, Singh SJ, Morgan MD, Pavord ID: Development of a symptom specific health status measure for patients with chronic cough: Leicester cough questionnaire (LCQ). Thorax 2003, 58:339-343.
• [20]American Thoracic Society and the European Respiratory Society: Ats/ers recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 2005, 171:912-930.
• [21]Raj AA, Pavord DI, Birring SS: Clinical cough iv: what is the minimal important difference for the Leicester cough questionnaire? In Pharmacology and therapeutics of cough. Edited by Chung KF, Widdicombe JG. Heidelberg: Springer; 2009:311-320.
• [22]Grossman J: One airway, one disease. Chest 1997, 111:11S-16S.
• [23]Camargos P, Ibiapina C, Lasmar L, Cruz AA: Obtaining concomitant control of allergic rhinitis and asthma with a nasally inhaled corticosteroid. Allergy 2007, 62:310-316.
• [24]Kharitonov SA, Yates DH, Barnes PJ: Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996, 153:454-457.
• [25]O’Connell F, Thomas VE, Pride NB, Fuller RW: Capsaicin cough sensitivity decreases with successful treatment of chronic cough. Am J Respir Crit Care Med 1994, 150:374-380.
• [26]Auffarth B, Postma DS, de Monchy JG, van der Mark TW, Boorsma M, Koeter GH: Effects of inhaled budesonide on spirometric values, reversibility, airway responsiveness, and cough threshold in smokers with chronic obstructive lung disease. Thorax 1991, 46:372-377.
• [27]Di Franco A, Dente FL, Giannini D, Vagaggini B, Conti I, Macchioni P, Scuotri L, Taccola M, Bacci E, Paggiaro PL: Effects of inhaled corticosteroids on cough threshold in patients with bronchial asthma. Pulm Pharmacol Ther 2001, 14:35-40.
• [28]Fujimura M, Hara J, Myou S: Change in bronchial responsiveness and cough reflex sensitivity in patients with cough variant asthma: effect of inhaled corticosteroids. Cough 2005, 1:5. BioMed Central Full Text
• [29]Nasra J, Belvisi MG: Modulation of sensory nerve function and the cough reflex: understanding disease pathogenesis. Pharmacol Ther 2009, 124:354-375.
• [30]Koskela HO, Purokivi MK, Nieminen RM, Moilanen E: Asthmatic cough and airway oxidative stress. Respir Physiol Neurobiol 2012, 181:346-350.